Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 2Polpharma
02 3Polfa Tarchomin
03 12care4
04 1Abboxia Ab
05 3Accord healthcare
06 6Actavis Inc
07 5Alembic Pharmaceuticals Limited
08 4Alphapharm PTY Ltd
09 2Apotex Inc
10 3Aurobindo Pharma Limited
11 3Avery Pharmaceuticals
12 5Barr Laboratories
13 1Biowise Pharmaceuticals, Sl
14 3Chartwell Pharmaceuticals llc
15 17Cheplapharm Arzneimittel Gmbh
16 14F. Hoffmann-La Roche
17 1Halewood Laboratories Pvt. Ltd
18 2Holsten Pharma Gmbh
19 4Indo Pharma
20 3Intas Pharmaceuticals
21 2MS Pharma
22 3Neuraxpharm
23 4ORIFARM GROUP AS
24 5PH HEALTH
25 3PHARMOBEDIENT
26 3PRO DOC LIMITEE
27 7Pharmaco
28 4Pharmaco Distribution
29 9Pharmascience Inc.
30 3Prinston
31 3R Key Enterprises
32 12RELIANCE FORMULATION PVT. LTD
33 2RIVOPHARM SA
34 4Ram Pharma
35 3Rubicon Research
36 3Sandoz B2B
37 8Sun Pharmaceutical Industries Limited
38 6Teva Pharmaceutical Industries
39 1Vaishali Pharma Ltd
40 3Verve Human Care Laboratories
41 1XL Laboratories Private Limited
42 1Xgx Pharma Aps
43 7Zim Laboratories
44 5Zota Healthcare Ltd
01 4Antic-calc Tablet
02 1Clonazepam 0.5Mg 20 Joined' Oral Use
03 1Clonazepam 2,5Mg/Ml 10Ml Oral Use
04 1Clonazepam 2Mg 20 Joined' Oral Use
05 1Concentrate And Solvent For Injectable Solution
06 4DC Granules and Tablets
07 1DRP
08 1INJ
09 1Injectable Solution
10 4Mouth Dissolving Tablet
11 3OD Tablet
12 1Oral Drop
13 3Oral Drops
14 1Oral Solution
15 3Orally Disintegrating Tablet
16 2Solution For Injection/Infusion
17 1Solution for Injection
18 8TAB
19 25TABLET
20 25TABLET, ORALLY DISINTEGRATING;ORAL
21 41TABLET;ORAL
22 39Tablet
23 2injection
24 4tablet
25 8Blank
01 6Allowed
02 6Approved
03 10Authorized
04 27DISCN
05 5Deregistered
06 3Dossier Available
07 13Generic
08 6Originator
09 39RX
10 11TARGETED SUBSTANCES (CDSA IV)
11 5Targeted (CDSA IV)
12 54Blank
01 2APO-CLONAZEPAM
02 1CLODAZOL
03 2CLONAM 0,5
04 2CLONAM 2
05 1CLONAPAX MD 0.25
06 1CLONAPAX MD 0.50
07 1CLONAPAX MD 1
08 1CLONAPAX MD 2
09 1CLONAPAX P-10
10 1CLONAPAX P-20
11 1CLONAPAX-0.5
12 1CLONAPAX-1
13 1CLONAPAX-2
14 56CLONAZEPAM
15 3CLOPAM
16 1Clonazepam Biomed
17 2Clonazepam Holsten
18 3Clonazepam Neuraxpharm
19 2Clonazepam Rivopharm
20 2Clonazepam Tzf
21 1ESCITAPAX PLUS
22 1ESCITAPAX PLUS - H
23 1ESCITAPAX PLUS - L
24 5Ictorivil
25 1Iqtopam
26 5KLONOPIN
27 5KLONOPIN RAPIDLY DISINTEGRATING
28 3Otril
29 3PMS-CLONAZEPAM
30 1PMS-CLONAZEPAM TAB 0.5MG
31 1PMS-CLONAZEPAM TAB 1.0MG
32 1PMS-CLONAZEPAM TAB 2MG
33 1PMS-CLONAZEPAM- TAB 0.25MG
34 1PMS-CLONAZEPAM-R
35 1PMS-CLONAZEPAM-R TAB 0.5MG
36 3PRO-CLONAZEPAM
37 2Paxam 0.5
38 2Paxam 2
39 2RIVOTRIL
40 4River Trial
41 4Rivoram
42 23Rivotril
43 1Rivotril 1mg/ml
44 28Blank
01 11Australia
02 16Canada
03 39India
04 3Italy
05 6Jordan
06 4Norway
07 3Poland
08 10South Africa
09 10Spain
10 11Sweden
11 6Switzerland
12 66USA
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Clonazepam Tzf
Dosage Form : Tablet
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2023-03-16
Application Number : 88731
Regulatory Info : Authorized
Registration Country : Spain
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Clonazepam Tzf
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging :
Approval Date : 2023-03-16
Application Number : 88732
Regulatory Info : Authorized
Registration Country : Spain
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1996-10-31
Application Number : 74869
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1996-10-31
Application Number : 74869
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.125MG
Packaging :
Approval Date : 1997-04-09
Application Number : 17533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 1997-04-09
Application Number : 17533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
